Patient-Centric Head and Neck Cancer Radiation Therapy: Role of Advanced Imaging.
Advanced imaging
Functional imaging
Head and neck cancer
Individualized
Personalized
Radiation planning
Tumor hypoxia
Journal
Neuroimaging clinics of North America
ISSN: 1557-9867
Titre abrégé: Neuroimaging Clin N Am
Pays: United States
ID NLM: 9211377
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
entrez:
1
7
2020
pubmed:
1
7
2020
medline:
27
4
2021
Statut:
ppublish
Résumé
The traditional 'one-size-fits-all' approach to H&N cancer therapy is archaic. Advanced imaging can identify radioresistant areas by using biomarkers that detect tumor hypoxia, hypercellularity etc. Highly conformal radiotherapy can target resistant areas with precision. The critical information that can be gleaned about tumor biology from these advanced imaging modalities facilitates individualized radiotherapy. The tumor imaging world is pushing its boundaries. Molecular imaging can now detect protein expression and genotypic variations across tumors that can be exploited for tailoring treatment. The exploding field of radiomics and radiogenomics extracts quantitative, biologic and genetic information and further expands the scope of personalized therapy.
Identifiants
pubmed: 32600635
pii: S1052-5149(20)30028-9
doi: 10.1016/j.nic.2020.04.005
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
341-357Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure R. Forghani has acted as speaker and consultant for GE Healthcare and has a research agreement (beta tester) and research support from GE Healthcare. R. Forghani is also a founder and stockholder of 4intelligent Inc.